Empery Asset Management, LP reports

Company location: New York, NY
Fiscal year end: 31 December

Empery Asset Management, LP has filed 467 SEC EDGAR filings since 31 Jul 2009

SEC filing history

Showing 101-125 of 464 matching filings.

Per page

25

Current page

5

SC 13G/A

ENVVENO MEDICAL CORPORATION

Filing date: 19 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

HEPION PHARMACEUTICALS, INC.

Filing date: 19 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ENVIROTECH VEHICLES, INC.

Filing date: 19 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CALADRIUS BIOSCIENCES, INC.

Filing date: 19 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VIVEVE MEDICAL, INC.

Filing date: 18 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

TIMBER PHARMACEUTICALS, INC.

Filing date: 18 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

OCUPHIRE PHARMA, INC.

Filing date: 18 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CASTOR MARITIME INC.

Filing date: 18 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

RING ENERGY, INC.

Filing date: 18 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

RED CAT HOLDINGS, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KIROMIC BIOPHARMA, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SECOND SIGHT MEDICAL PRODUCTS, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ATOSSA THERAPEUTICS, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

APPLIED DNA SCIENCES INC

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

22ND CENTURY GROUP, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ENGLOBAL CORPORATION

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VIRTRA, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ION GEOPHYSICAL CORP

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AETHLON MEDICAL, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VISLINK TECHNOLOGIES, INC.

Filing date: 11 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

U.S. ENERGY CORP.

Filing date: 11 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ORBITAL ENERGY GROUP, INC.

Filing date: 11 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

LANTERN PHARMA INC.

Filing date: 11 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KEMPHARM, INC.

Filing date: 11 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

EYEGATE PHARMACEUTICALS, INC.

Filing date: 20 Aug 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .